Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
|
Exanthem
|
eruptive disease and eruptive fever
|
|
|
Enanthem
|
eruption upon mucos membrane
|
|
|
F. Paramyxoviridae
Mumps Epi. |
saliva/oral secretions
communicable 7 d prior 9 after 5-15 y.o. highest freq. late winter/spring |
|
|
F. Paramyxoviridae
Mumps Pathogenesis |
resp. tract
viremia/viruria widespread to salivary, CNS, kidney, pancreas Incubation 16-18 days |
|
|
F. Paramyxoviridae
Mumps Clinical |
asymptomatic in 1/3
fever, swelling of salivary earache, facial pain focued in parotid gland |
|
|
F. Paramyxoviridae
Mumps Diagnosis |
Lemon juice increase salvation
culture |
|
|
F. Paramyxoviridae
Mumps Treatment |
no treatment
live vaccine |
|
|
F. Paramyxoviridae
Measles Epi. |
high attack rate
saliva/oral secretions or resp. tract or conjunctiva communicable 5 prior and 4 after winter/spring; 1-3 yr cycle |
|
|
F. Paramyxoviridae
Measles Pathogenesis |
resp. epi.
dissemination via blood & lymph infects WBC (neutro and lympho) Incubation period 10 days |
|
|
F. Paramyxoviridae
Measles Clinical |
4 Cs
Cough, coryza, conjunctivitis, and Koplik spots |
|
|
F. Paramyxoviridae
Measles Koplik spots |
pinpoint grey/white or blue/white
mucous membrane, buccal |
|
|
F. Paramyxoviridae
Measles Compliations |
SSPE (subacute sclerosisng panencephalitis)
rare neurologic disorder |
|
|
F. Paramyxoviridae
Measles Diag |
clinical presentation
culture |
|
|
F. Paramyxoviridae
Measles Treatment |
supportive, vit. A, live vaccine
|
|
|
F. Herpesviridae
Roseola (Herpesvirus 6) Characteristics |
large, dsDNA, enveloped
|
|
|
F. Herpesviridae
Roseola (Herpesvirus 6) Epi |
incubation 10-15 d.
|
|
|
F. Herpesviridae
Roseola (Herpesvirus 6) Clinical |
High fever for 4 days
febrile seziures very fine rash |
|
|
F. Herpesviridae
Roseola (Herpesvirus 6) Treatment |
no treatment/vaccine
|
|
|
F. Parvoviridae
Fifth Disease/Parvovirus B19 Characteristics |
ssDNA; no envelope
|
|
|
F. Parvoviridae
Fifth Disease/Parvovirus B19 Pathogenesis |
viremia
replicate in nucleus of immature RBC in bone marrow |
|
|
F. Parvoviridae
Fifth Disease/Parvovirus B19 Clinical |
mild fever
headache myalgia mild decrease in WBC and RBC |
|
|
F. Parvoviridae
Fifth Disease/Parvovirus B19 Clinical |
slapped cheek rash
gloves and socks syndrome, rash on extremities |
|
|
F. Parvoviridae
Fifth Disease/Parvovirus B19 Complications |
fetus: hydrops fetalis and death
hemoglobinopathy: anemia immunocomp: persistent infection |
|
|
F. Parvoviridae
Fifth Disease/Parvovirus B19 treatment |
no treatment/vaccine
|
|
|
F. Togaviridae
Rubella Characteristics |
+ssRNA; enveloped
cell membrane has viral glycoproteins |
|
|
F. Togaviridae
Rubella Patho. |
Resp. tract
16 d. incubation |
|
|
F. Togaviridae
Rubella Clinical |
low fever; URT; lympandenopathy
discrete pink fine rash beginning on face. |
|
|
F. Togaviridae
Rubella Clinical |
Forscheimer spots
arthralgia/arthritis low grade fever; respiratory symptoms, LYMPHADENOPATHY. discrete pink fine rash beginning on face |
|
|
F. Togaviridae
Rubella Diag/treatment |
culture/serology
no treatment live vaccine |
|
|
Rosela - HSV6
Clinical progression of 3 stages |
1. Infant/child has high fever
2. fever ressolves as irr. macules appear on face and neck 3. can have febrile seziures in infants |
